By IBTimes
Air pollution may be declining, but over 40 percent of the U.S. population lives in areas where pollution makes breathing dangerous, according to a report by the American Lung Association (Apr 30)
MORE TOPICS:
CALIFORNIA, CANCER
By IBTimes
Drug trials tend to ignore child patients who account for a larger proportion of overall disease burden and instead focus on adults, according to new research presented Saturday. (Apr 28)
By IBTimes UK
12-year-old girl may have died as result of allergic reaction to something in her chips, inquest told. (Apr 27)
MORE TOPICS:
FACEBOOK, ALLERGY
By IBTimes
Beach season is right around the corner and many are looking for some weight loss option to help burn those last few pounds left over from the holiday festivities. Most recently, Dr. Oz promoted a supplement called forskolin to blast belly fat. (Apr 21)
By IBTimes UK
Scientists from the University of Southampton and Synairgen Company have found a drug that protects asthma patients from respiratory virus infections. (Apr 20)
MORE TOPICS:
INFECTION
By IBTimes UK
Phthalates, a chemical used in cosmetics can increase risk of diabetes and obesity, according to a study. (Apr 15)
MORE TOPICS:
ALLERGY
By Women Fitness
Binge-eating followed by purging with self-induced vomiting and the compulsive use of laxatives, are warning signs of this condition. Its causes include low body image and a feeling of not being in control. It is often associated with anorexia. (Apr 13)
MORE TOPICS:
ARTHRITIS
By Natural News
A study published in the March 2012 issue of Pediatrics, the journal of the American Association of Pediatrics, has shown again how important vitamin D3 supplementation is during pregnancy. (Apr 09)
By Health Canal
PITTSBURGH-Stress wreaks havoc on the mind and body. For example, psychological stress is associated with greater risk for depression, heart disease and infectious diseases. But, until now, it has not been clear exactly how stress influences disease and health. (Apr 03)
MORE TOPICS:
INFECTION
By IBTimes UK
AstraZeneca, an Anglo-Swedish biopharmaceutical company has entered into an agreement with Amgen, US biotechnology company to develop and commercialise five monoclonal antibodies from Amgen's clinical inflammation portfolio. (Apr 03)